TPG Group Holdings (SBS) Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$398M Buy
1,067,795
+8,245
+0.8% +$3.13M 3.95% 7
2021
Q2
$405M Sell
1,059,550
-50,065
-5% -$19.1M 2.88% 7
2021
Q1
$398M Buy
1,109,615
+195,415
+21% +$62.8M 4.65% 6
2020
Q4
$294M Buy
914,200
+534
+0.1% +$164K 3.25% 8
2020
Q3
$245M Buy
913,666
+44,042
+5% +$11.9M 4.4% 9
2020
Q2
$229M Sell
869,624
-21,643
-2% -$5.77M 4.04% 8
2020
Q1
$202M Buy
891,267
+177,699
+25% +$48.4M 4.66% 8
2019
Q4
$216M Buy
713,568
+130,340
+22% +$35.9M 3.18% 9
2019
Q3
$140M Buy
583,228
+219,977
+61% +$60.3M 2.06% 12
2019
Q2
$103M Buy
+363,251
New +$99.2M 1.54% 13

Other funds holding ELV

TPG Group Holdings (SBS) Advisors's ELV Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors increased its Elevance Health (ELV) stake by 0.78% in Q3 2021, buying an estimated $3.13M and bringing the position to 1,067,795 shares worth $398M. The position accounts for 3.95% of the portfolio, ranked #7.

TPG Group Holdings (SBS) Advisors first reported a position in ELV in Q2 2019 and has held it in 10 quarters since. The position peaked at $405M in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • TPG Group Holdings (SBS) Advisors held 1,067,795 shares of Elevance Health worth $398M as of Q3 2021.
  • TPG Group Holdings (SBS) Advisors bought 8,245 Elevance Health shares in Q3 2021, an estimated $3.13M.
  • Elevance Health made up 3.95% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #7 holding.
  • TPG Group Holdings (SBS) Advisors first reported a position in Elevance Health in Q2 2019 and has held it in 10 quarters since.
  • TPG Group Holdings (SBS) Advisors's Elevance Health position peaked at $405M in Q2 2021.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.